Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues
Arcus Biosciences, Inc. (RCUS) had Pre-Tax Profit Margin of -1422.22% for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$9.00M |
|
$-128.00M |
|
-- |
|
$9.00M |
|
$140.00M |
|
$-131.00M |
|
$3.00M |
|
$-128.00M |
|
$-128.00M |
|
$-128.00M |
|
$-128.00M |
|
$-128.00M |
|
$-128.00M |
|
$-131.00M |
|
$-131.00M |
|
127.40M |
|
127.40M |
|
$-1.00 |
|
$-1.00 |
|
| Balance Sheet Financials | |
$664.00M |
|
$33.00M |
|
$154.00M |
|
$818.00M |
|
$199.00M |
|
$102.00M |
|
$261.00M |
|
$460.00M |
|
$358.00M |
|
$358.00M |
|
$358.00M |
|
127.60M |
|
| Cash Flow Statement Financials | |
$-345.00M |
|
$248.00M |
|
$26.00M |
|
$225.00M |
|
$154.00M |
|
$-71.00M |
|
$50.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.34 |
|
-- |
|
-- |
|
0.22 |
|
0.28 |
|
100.00% |
|
-1455.56% |
|
-1455.56% |
|
-- |
|
|
Pre-Tax Profit Margin |
-1422.22% |
-1422.22% |
|
$-345.00M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.50 |
|
180.00 |
|
-35.75% |
|
-35.75% |
|
-15.65% |
|
-27.83% |
|
$2.81 |
|
$-2.71 |
|
$-2.71 |
|